secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2022-12-23T23:59:59+00:00
Accession:  0001683168-22-008632
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals enters ATM equity offering agreement for up to $2.7M
---------------------------------------------------------------------------

- ATM agreement with Ladenburg Thalmann to sell common stock up to $2,700,000 aggregate gross proceeds.
- Ladenburg receives 3% commission on sales; Company reimburses up to $60,000 in expenses.
- Sales conducted under existing effective S-3 shelf registration (filed Dec 22, 2020).
- Company not obligated to sell any shares; agreement terminates upon completion or earlier per terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316822008632/0001683168-22-008632-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316822008632/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-008632

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer